MedPath

Inspiratory Muscle Strength Training for Sleep-related Breathing Disorders

Not Applicable
Completed
Conditions
Obstructive Sleep Apnea
Registration Number
NCT02709941
Lead Sponsor
University of Arizona
Brief Summary

The purpose of the current study is to investigate the effects of a novel breathing training, called inspiratory muscle strength training (IMST), on sleep patterns, breathing and blood pressure for patients diagnosed with mild, moderate and severe sleep apnea.

Detailed Description

Aims of the study:

1. To determine the influence of IMST on resting blood pressure and baroreceptor sensitivity.

2. To determine the effect of IMST on sympathetic nervous system by measuring plasma cathecholamines and nerve recording (MSNA).

Population:

30 subjects aged 30-75 years, who have previously been diagnosed with obstructive sleep apnea, as defined by the National Institutes of Health (National Heart Lung, and Blood Institute) will be included in this study.

Study Protocol:

* Pre-training assessment and overnight sleep study

* 5-10 minutes each day breathing training (IMST) at home using a hand-held device for 6 weeks

* Once weekly laboratory visit

* Post-training assessment and overnight sleep study

Pre- and post-training assessment include blood pressure measurement, body weight, neck circumference, cardiorespiratory monitoring, nerve recording, blood draw and sleep surveys.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Age 30-75 years
  • Diagnosed with Obstructive Sleep Apnea with Apnea Hypopnea Index (AHI) > 15
  • Neck circumference > 16 cm
Exclusion Criteria
  • Body mass index (BMI) > 40kg/m2
  • Implanted pacemaker
  • On anticoagulant medication
  • On hypnotic medication
  • On immunosuppressive medication
  • Acute or recent (3 months prior to study) infection
  • History of hypothyroidism
  • History of stroke or neuromuscular disease
  • Moderate to severe heart failure
  • Severe ischemic heart disease
  • Severe obstructive and restrictive lung disease
  • Cor pulmonale
  • Cognitive disorders
  • Obstructive nasal disease or history of spontaneous pneumothorax or rib fracture
  • History of neurological, respiratory, head /neck, or thoracic surgery

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Systolic and diastolic blood pressures (mmHg)Weekly blood pressure measures obtained each week for 6 weeks

Blood pressure measured with blood pressure cuff and syphygmomanometer via standard auscultation technique.

Secondary Outcome Measures
NameTimeMethod
Apnea hypopnea indexPrior to and upon completion of the 6-weeks respiratory strength training.

Documentation of the total number of apneas and hypopneas experienced by the individuals per hour of sleep and expressed as the apnea-hypopnea index or AHI which has the following ranges; \<5 normal; 5-15 mild, 15-30 moderate and \>30 severe AHI.

Sleep Quality Survey (PSQI)Prior to and upon completion of the 6-weeks training.

This is a rating scale of overall sleep quality ranging from 0-21 with values \<5 rated as indicative of normal or good sleep quality and a score of 21 indicative of most severe sleep disturbance.

Plasma cathecholamines (epinephrine, norepinephrine and dopamine)Blood draw taken prior to and upon completion of the 6-weeks respiratory strength training.

Plasma catecholamines are determined via morning blood draw taken after 20 minutes supine rest. Reference ranges for plasma catecholamines are as follows: plasma epinephrine is 10-200 pg/ml; plasma norepinephrine 80-250 pg/ml and plasma dopamine 0-20 pg/ml.

Trial Locations

Locations (1)

Department of Physiology at the University of Arizona

🇺🇸

Tucson, Arizona, United States

Department of Physiology at the University of Arizona
🇺🇸Tucson, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.